Doximity, Inc. (NYSE
OCS) is among the most promising growth stocks according to analysts. On January 9, Raymond James reaffirmed a ‘Strong Buy’ rating on Doximity, Inc. (NYSEOCS) and a $65 price target. The firm highlighted OpenAI’s recent entry into healthcare AI tools, which it believes is…Continue reading...